Combination Immunotherapy For Advanced Melanoma - Phase 1b Trial Results Encouraging
Monday, June 2, 2014 - 11:50
in Health & Medicine
Long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results — long-lasting, with high survival rates — according to a presentation at the 2014 annual conference of the American Society of Clinical Oncology (ASCO) in Chicago. read more